Skip to content

Author

Xi-Peng Wang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

The dual immune landscape of homologous recombination-deficient tumors: mechanisms and therapeutic implications

Homologous recombination deficiency (HRD) is a major genomic feature of several malignancies and provides a therapeutic rationale for DNA-damaging agents and PARP inhibitors. Beyond its role in genome instability, accumulating evidence suggests that HRD also reshapes the tumor microenvironment (TME). However, the immun...

Yi-Ting Yang, Yu-Jia Yin, Sheng-Xin Rong et al. · 0 citations
Open access Aug 2026

PD09.07. Impact of Type 2 Diabetes on Outcomes of Neoadjuvant Therapy and Surgery for Esophageal Cancer: A Multi-Center Retrospective Study

Esophageal Cancer: Surgical Treatment of Esophageal Cancer – early outcomes and complications The prognostic impact of type 2 diabetes in esophageal cancer patients receiving neoadjuvant therapy followed by surgery remains unclear. We evaluated its association with perioperative outcomes and long-term surv...

Xi-Peng Wang, Zhi-Chao Liu, Xue-Feng Leng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.